Gladstone Institutional Advisory’s Transmedics TMDX Stock Holding History

Gladstone Institutional Advisory’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Sell	16,564 -31	-0.2%	-$2.62K	0.03%	396
2026 Q1	$1.65M	Sell	16,595 -10	-0.1%	-$1.3K	0.06%	295
2025 Q4	$2.02M	Sell	16,605 -89	-0.5%	-$11.2K	0.08%	252
2025 Q3	$1.87M	Buy	16,694 +8,810	+112%	+$1.03M	0.07%	258
2025 Q2	$1.06M	Buy	7,884 +25	+0.3%	+$2.75K	0.04%	338
2025 Q1	$529K	Sell	7,859 -2,000	-20%	-$138K	0.02%	453
2024 Q4	$615K	Buy	+9,859	New	+$918K	0.03%	418
2021 Q4	–	Sell	-14,270	Closed	-$472K	–	633
2021 Q3	$472K	Sell	14,270 -1,200	-8%	-$36.7K	0.05%	342
2021 Q2	$513K	Sell	15,470 -3,100	-17%	-$85.9K	0.06%	295
2021 Q1	$770K	Buy	+18,570	New	+$572K	0.12%	180

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Gladstone Institutional Advisory's TMDX Position: Q2 2026 in Review

Gladstone Institutional Advisory reduced its Transmedics (TMDX) stake by 0.19% in Q2 2026, selling an estimated $2.62K and leaving 16,564 shares worth $1.1M. The position accounts for 0.03% of the portfolio, ranked #396.

Gladstone Institutional Advisory first reported a position in TMDX in Q1 2021 and has held it in 10 quarters since. The position peaked at $2.02M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Gladstone Institutional Advisory held 16,564 shares of Transmedics worth $1.1M as of Q2 2026.
Gladstone Institutional Advisory sold 31 Transmedics shares in Q2 2026, an estimated $2.62K.
Transmedics made up 0.03% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #396 holding.
Gladstone Institutional Advisory first reported a position in Transmedics in Q1 2021 and has held it in 10 quarters since.
Gladstone Institutional Advisory's Transmedics position peaked at $2.02M in Q4 2025.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.